Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids

Abstract

Women who are carriers of the ornithine transcarbamylase (OTC) mutation are at risk for developing hyperammonemia during the postpartum period and at times of metabolic stress. We present a unique case of hyperammonemic coma occurring in an OTC mutation carrier during the antepartum period. Multiple factors, including the administration of antenatal corticosteroids, likely precipitated this critical condition. Clinicians should be aware of this life-threatening clinical presentation and be prepared to identify, treat, and prevent hyperammonemia in affected individuals.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Peterson DE . Acute postpartum mental status change and coma caused by previously undiagnosed ornithine transcarbamylase deficiency. Obstet Gynecol 2003; 102: 1212–1215.

    PubMed  Google Scholar 

  2. Summar ML, Barr F, Dawling S, Smith W, Lee B, Singh RH et al. Unmasked adult-onset urea cycle disorders in the critical care setting. Crit Care Clin 2005; 21: S1–S8.

    Article  Google Scholar 

  3. Cordero DR, Baker J, Dorinzi D, Toffle R . Ornithine transcarbamylase deficiency in pregnancy. J Inherit Metab Dis 2005; 28 (2): 237–240.

    Article  CAS  Google Scholar 

  4. Smith W, Kishnani PS, Lee B, Singh RH, Rhead WJ, King LS et al. Urea cycle disorders: clinical presentation outside the newborn period. Crit Care Clin 2005; 21: S9–17.

    Article  Google Scholar 

  5. Gaspari R, Arcangeli A, Mensi S, Wismayer DS, Tartaglione T, Antuzzi D et al. Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma. Ann Emerg Med 2003; 41: 104–109.

    Article  Google Scholar 

  6. Gordon N . Ornithine transcarbamylase deficiency: a urea cycle defect. Eur J Paediatr Neurol 2003; 7: 115–121.

    Article  Google Scholar 

  7. Schimanski U, Krieger D, Horn M, Stremmel W, Wermuth B, Theilmann L . A novel tow-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonemia in early pregnancy. Hepatology 1996; 24 (6): 1413–1415.

    Article  CAS  Google Scholar 

  8. Atiq M, Holt A, Safdar K, Weber F, Ravinuthala R, Jonas M et al. Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy. J Clin Gastroenterol 2008; 42: 213–214.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D W Ouyang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipskind, S., Loanzon, S., Simi, E. et al. Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids. J Perinatol 31, 682–684 (2011). https://doi.org/10.1038/jp.2011.23

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2011.23

Keywords

This article is cited by

Search

Quick links